Case 3-An 18 year old woman received a kidney from her mother. Hyperimmune gammaglobulin was given preoperatively in a dose of 5 ml, and a total of three doses were given at three monthly intervals. Good graft function was achieved, and the serum creatinine concentration three years after renal transplantation was 86 Ftmol/l. One year after operation the patient developed antibodies to hepatitis B surface antigen, which persisted. Transaminase activities were normal throughout.
Comment
To discard kidneys from donors positive for hepatitis B surface antigen means discarding kidneys from 10% of potential donors, for such is the rate of carriage of hepatitis B surface antigen among the general population in Hong Kong.3 Our patients did not receive donor specific blood transfusions, and the blood transfused at the time of the operation was negative for hepatitis B surface antigen. The donor kidney was therefore the only parenteral source of hepatitis B surface antigen to which the patients were exposed.
None of our donors were positive for e antigen, which suggests that the donor kidneys may not have been particularly infectious since the presence of e antigen is an index of infectivity. Nevertheless, all except one of the recipients had evidence ofexposure to the hepatitis B virus before renal transplantation since they had antibodies to the core antigen. Furthermore, two patients developed persistent and one transient antibodies to hepatitis B surface antigen, indicating that the donor kidney (or the blood it contained) had been an important source of the viral surface antigen.
Our experience suggests that with the use of hyperimmune gammaglobulin it is safe to use kidneys from donors positive for hepatitis B surface antigen but negative for e antigen for transplantation in patients who are negative for hepatitis B surface antigen. 
Patients, methods, and results
Case I-A 79 year old woman with active rheumatoid arthritis who was taking naproxen 500 mg twice daily was found to have a serum potassium concentration of 7 3 mmol/l (normal 3-5-5-0 mmol/l) on routine testing. Haemoglobin concentration was 108 g/l, platelet count 1260x 10/1, and white cell count 11 9x 109/l. Bone marrow was normal. The naproxen was stopped and dextrose-insulin and calcium polystyrene sulphonate started, but she continued to have intermittent episodes of hyperkalaemia. Pseudohyperkalaemia was diagnosed and was confirmed by simultaneous measurements of serum and plasma potassium concentrations (4 7 and 3-4 mmol/l respectively; difference 1-3 mmol/l).
Case 2-A 70 year old woman with active rheumatoid arthritis who was taking ibuprofen 400 mg thrice daily was found to have a serum potassium concentration of 5-7 mmol/l on routine testing. This raised concentration persisted after ibuprofen was withdrawn. Haemoglobin 
The median (range) difference in potassium concentration between serum and plasma in the 43 patients with rheumatoid arthritis was 0 3 (0 1-1 3) mmol/l, which was significantly greater (p<0 001) than that in the 21 controls with arthritis (0 2 (0-0 4) mmol/l) and the 28 normal subjects (0 2 (0-0-4) mmol/l). Serum creatinine and plasma potassium concentrations and the white cell count were similar in the three groups, but the platelet count was significantly (p<0-001) higher in the patients with rheumatoid arthritis (median (range) 366 (165-1260)x 103/1 v 287 (122-444)x 107/1 in the controls with arthritis and 305 (192-440)x 107/1 in the normal subjects). The difference in potassium concentration between serum and plasma in the patients with rheumatoid arthritis correlated with their platelet count ( figure) (r=0 64, p<0001 ).
Comment
We are not aware of other reports of pseudohyperkalaemia occurring in conditions such as rheumatoid arthritis. We found that in normal subjects the median serum potassium concentration was 0-2 mmol/l higher than the plasma potassium concentration, which confirms a previous report. 4 We found a similar difference in our control group of patients with arthritis who were taking non-steroidal antiinflammatory drugs, which excludes these as the cause of the pseudohyperkalaemia. In contrast, the difference in concentrations was significant in the patients with rheumatoid arthritis, with values of 1 5 mmol/l being recorded (case 2). The pseudohyperkalaemia may have been due to the raised platelet count in view of the correlation between it and the difference between serum and plasma potassium concentrations.
Failure to recognise pseudohyperkalaemia in our patients led to errors in management: one patient was given treatment to lower her potassium concentration Relation between platelet count and difference in potassium concentration between serum and plasma (potassium difference) in 43 patients with rheumatoid arthritis. Area enclosed by broken line indicates reference rangesfor both variables in normal subjects and one had her treatment with a non-steroidal antiinflammatory drug stopped unnecessarily. Our data suggest that pseudohyperkalaemia may be common and often overlooked in active rheumatoid arthritis. It may easily be confirmed by concurrent measurements of serum and plasma potassium concentrations, a difference >0 40 mmol/l being diagnostic.
We thank Drs Stephanie Armstrong and Alison Trainer for help with collecting the blood samples. There have been few studies to determine the size of the problem of eye disease related to contact lenses in a community or to compare the risks of complications associated with different types of lenses.'? We therefore performed a case-control study to estimate the relative risks.
Patients, methods, and results
All patients who wore contact lenses and attended the High Holborn branch of Moorfields Eye Hospital between 1 January and 31 March 1986 were included in the study. Disorders related to contact lenses were diagnosed from previously agreed clinical criteria; the conditions were grouped for analysis according to pathogenesis.
Of 393 patients (152 men, 241 women) who wore contact lenses, 329 had problems related to wearing lenses; 64 patients who wore lenses attended for an unrelated ocular problem. One hundred and ninety patients wore daily wear soft lenses, 45 extended wear soft lenses, 100 polymethylmethacrylate hard lenses, and 58 gas permeable hard lenses. Two hundred and seventeen patients were aged 20-29. Of the 393, 367 patients obtained their lenses privately and 26 were fitted by hospital eye departments. Ten patients wore lenses for aphakia, six for keratoconus, and 14 for high myopia. The rest wore lenses in preference to spectacles for low refractive errors.
The main groups of conditions seen were metabolic (principally corneal hypoxia), toxic and hypersensitivity reactions, corneal abrasions, and infections. Five cases of bacterial keratitis were diagnosed, all in patients who wore soft lenses. Problems related to contact lenses accounted for 10% of all attendances at the casualty department.
The relative risk associated with each type of lens for a disorder was estimated by calculating the odds ratio from contingency tables. Hard lenses were hypothesised to have the least risk of complications before the analysis, for which the polymethylmethacrylate hard lens was taken as the referent, with a baseline risk of 10. The risks for other lenses were estimated as multiples of this. The significance of the increasing risks was estimated with the Mantel-Haenszel x2 test of trend. The overall risk for soft lenses compared with
